|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
537,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,021,652 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
785,387 |
|
|
Total
Value |
$64,960,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
851 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 21 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-29 |
4 |
OE |
$37.46 |
$187,300 |
D/D |
5,000 |
339,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-29 |
4 |
AS |
$81.95 |
$409,750 |
D/D |
(5,000) |
334,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-08 |
4 |
D |
$65.32 |
$357,888 |
D/D |
(5,479) |
112,838 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-08 |
4 |
D |
$56.78 |
$311,098 |
D/D |
(5,479) |
189,756 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-08 |
4 |
D |
$121.66 |
$666,575 |
D/D |
(5,479) |
243,175 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-06 |
4 |
D |
$80.80 |
$442,703 |
D/D |
(5,479) |
390,156 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-22 |
4 |
D |
$78.52 |
$433,352 |
D/D |
(5,519) |
302,498 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-16 |
4 |
D |
$77.21 |
$429,210 |
D/D |
(5,559) |
308,017 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-03-16 |
4 |
D |
$80.72 |
$448,803 |
D/D |
(5,560) |
334,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-24 |
4 |
OE |
$12.99 |
$77,940 |
D/D |
6,000 |
173,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-24 |
4 |
AS |
$48.38 |
$290,252 |
D/D |
(6,000) |
178,691 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2015-09-10 |
4 |
B |
$3.05 |
$18,293 |
D/D |
6,000 |
39,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-09 |
4 |
OE |
$17.33 |
$103,980 |
D/D |
6,000 |
212,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-09 |
4 |
AS |
$90.18 |
$541,080 |
D/D |
(6,000) |
206,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-01-08 |
4 |
OE |
$14.39 |
$86,340 |
D/D |
6,000 |
294,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-01-08 |
4 |
AS |
$91.14 |
$549,523 |
D/D |
(6,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-15 |
4 |
OE |
$37.46 |
$224,760 |
D/D |
6,000 |
309,689 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-15 |
4 |
AS |
$82.71 |
$496,260 |
D/D |
(6,000) |
303,689 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-16 |
4 |
OE |
$37.46 |
$224,760 |
D/D |
6,000 |
309,689 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-16 |
4 |
AS |
$84.68 |
$508,080 |
D/D |
(6,000) |
303,689 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-13 |
4 |
AS |
$109.15 |
$654,900 |
D/D |
(6,000) |
320,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-13 |
4 |
OE |
$67.81 |
$406,860 |
D/D |
6,000 |
326,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-08-08 |
4 |
S |
$88.29 |
$529,740 |
D/D |
(6,000) |
422,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-06-04 |
4 |
D |
$92.07 |
$580,962 |
D/D |
(6,310) |
284,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-04 |
4 |
AS |
$17.70 |
$116,163 |
D/D |
(6,500) |
16,642 |
0 |
- |
|
851 Records found
|
|
Page 21 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|